Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 77

Results For "FY"

2303 News Found

Pharma stalwarts demystify COVID-19 impact on industry
News | March 01, 2021

Pharma stalwarts demystify COVID-19 impact on industry

Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.


Glenmark Q3 FY21 net profit up 30% at Rs 248 Cr
News | February 15, 2021

Glenmark Q3 FY21 net profit up 30% at Rs 248 Cr

The jump in profit is due to the better performance of the API business.


SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr
News | February 11, 2021

SMS Pharmaceuticals Q3FY21 consolidated PAT up to Rs. 21.39 Cr

The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.


Sun Pharma Advanced Research Q3FY21 loss at Rs. 67.62 crore
News | February 11, 2021

Sun Pharma Advanced Research Q3FY21 loss at Rs. 67.62 crore

The company posted net loss of Rs. 55.51 crores for the period ended December 31, 2019.


J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr
News | February 11, 2021

J B Chemicals & Pharmaceuticals Q3FY 21 consolidated PAT up at Rs. 151.66 Cr

The company posted net profit of Rs.62.17 crores for the period ended December 31, 2019.


Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr
News | February 08, 2021

Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr

The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.


Cadila Healthcare Q3FY21 consolidated PAT up at Rs. 527.2 Cr
News | February 06, 2021

Cadila Healthcare Q3FY21 consolidated PAT up at Rs. 527.2 Cr

The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.


Pfizer registers Q3FY21 PAT at Rs. 141.24 Cr
News | February 06, 2021

Pfizer registers Q3FY21 PAT at Rs. 141.24 Cr

The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.


GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr
News | February 06, 2021

GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr

The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.


Dr. Reddy's Laboratories reports Rs. 19.8 Cr PAT in Q3FY21
News | February 01, 2021

Dr. Reddy's Laboratories reports Rs. 19.8 Cr PAT in Q3FY21

The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.